Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock
-
Total 13F shares
-
282,883
-
Share change
-
-17,464
-
Total reported value
-
$5,326,910
-
Price per share
-
$18.85
-
Number of holders
-
8
-
Value change
-
-$320,150
-
Number of buys
-
1
-
Number of sells
-
4
Institutional Holders of CHUGAI PHARMACEUTICAL CO - Common Stock (CHGCY) as of Q4 2023
As of 31 Dec 2023,
CHUGAI PHARMACEUTICAL CO - Common Stock (CHGCY) was held by
8 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
282,883 shares.
The largest 8 holders included
TODD ASSET MANAGEMENT LLC, RHUMBLINE ADVISERS, PNC FINANCIAL SERVICES GROUP, INC., RIVERBRIDGE PARTNERS LLC, GAMMA Investing LLC, Tradition Wealth Management, LLC, Operose Advisors LLC, and Accent Capital Management, LLC.
This page lists
8
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.